First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results